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Abstract The disrupted metabolism of homocysteine (Hcy)
causes hyperhomocysteinemia, a condition associated with the
impairment of nitric oxide (NO) bio-availability, tissue hypoxia
and increased risk of vascular disease. Here, we examined how
Hcy modulates the induction of the stress protein haem
oxygenase-1 (HO-1) evoked by NO releasing agents and
hypoxia in vascular endothelial cells. We found that Hcy (0.5
mM) markedly reduced the increase in haem oxygenase activity
and HO-1 protein expression induced by sodium nitroprusside
(SNP, 0.5 mM) but did not affect HO-1 activation mediated by
S-nitroso-N-acetyl-penicillamine. Cells pre-treated with Hcy
followed by addition of fresh medium containing SNP still
exhibited an augmented haem oxygenase activity. Interestingly,
high levels of Hcy were also able to abolish hypoxia-mediated
HO-1 expression in a concentration-dependent manner. These
novel findings indicate that hyperhomocysteinemia interferes
with crucial signaling pathways required by cells to respond and
adapt to stressful conditions. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Increased plasma homocysteine (Hcy) levels have become
widely accepted as an independent risk factor for vascular
disease [1,2]. Hyperhomocysteinemia, a condition that arises
from disrupted Hcy metabolism, is caused by both genetic and
dietary disorders and has been implicated in the pathophysi-
ology of atherosclerosis [3]. Moderate hyperhomocysteinemia
has been found in 20^30% of patients with coronary and
peripheral vascular disease and levels of Hcy may be as high
as 200^300 WM in homocysteinuria [4,5]. Hcy is a sulphur-
containing amino acid whose metabolism stands at the inter-
section of two pathways: remethylation to methionine, which
requires folate and vitamin B12, and trans-sulphuration to
cystathionine, which requires pyridoxal-5P-phosphate [6]. The
mechanism(s) whereby impaired Hcy metabolism leads to the
development of vascular dysfunction is poorly understood.
Previous studies have shown that Hcy evokes adverse vascular
e¡ects by promoting oxidative damage to endothelial cells
[1,7]. These cytotoxic e¡ects appear to be caused by an in-
creased production of hydrogen peroxide during the auto-ox-
idation of the sulfhydryl group and may account for the ob-
served endothelial dysfunction mediated by elevated Hcy
levels [4^6]. Alteration of the vascular responses of normal
endothelial cells by Hcy has also been attributed to the high
reactivity of this metabolite with nitric oxide (NO) [1,8]. In-
deed, thiols are critical sites of reaction for NO and NO-re-
lated species in biological systems, leading to the formation of
S-nitrosothiols [9,10]. S-Nitrosohomocysteine is formed under
physiological conditions [8] and the presence of thiols in the
surrounding intracellular milieu determine its stability, reac-
tivity and, consequently, its cytoprotective or cytotoxic action
[11].
In view of its capacity to interact with NO and promote
oxidative stress to the vascular wall, there exists the possibility
that increased Hcy levels may a¡ect the expression of intra-
cellular defensive genes that are induced in response to stress-
ful conditions. We have demonstrated that haem oxygenase-1
(HO-1), a redox sensitive inducible protein which is crucial for
the resolution of several disorders, is potently induced by NO
and NO-related species in aortic endothelial cells [12^15]; this
e¡ect results in increased haem oxygenase activity which pro-
tects vascular cells against oxidative stress and cell death
[13,16,17]. The induction of HO-1 by exogenous and endoge-
nously produced NO is prevented by increased glutathione
production and is ¢nely modulated by redox reactions involv-
ing the formation of S-nitrosothiols [12,15]. It is, therefore,
plausible to suggest that other compounds containing sul-
phydryl residues could in£uence the expression of HO-1 in
response to stressful stimuli. In the present study, we inves-
tigated the e¡ect of high levels of Hcy on HO-1 expression
and haem oxygenase activation mediated by NO and low oxy-
gen tension (hypoxia) in cultured vascular endothelial cells.
2. Materials and methods
2.1. Reagents
S-Nitroso-N-acetylpenicillamine (SNAP) was obtained from Alexis
Corporation (Bingham, Nottingham, UK). Sodium nitroprusside
(SNP), Hcy and all other chemicals were obtained from Sigma-Al-
drich (Poole, Dorset, UK) unless otherwise speci¢ed.
2.2. Cell culture and hypoxia
Bovine aortic endothelial cells were purchased from the American
Type Culture Collection (Manassas, VA, USA), cultured in 75 cm2
£asks and grown in Iscove’s modi¢ed Dulbecco’s medium supple-
mented with 10% foetal bovine serum, 2 mM L-glutamine, penicillin
(100 U/ml) and streptomycin (0.1 mg/ml). For the experiments con-
ducted under hypoxic conditions, endothelial cells at con£uence were
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transferred to an air-tight chamber (Billups-Rothenberg, Del Mar,
CA, USA) and £ushed with a mixture of 95% N2^5% CO2. The gas
was infused continuously into the air-tight chamber at a £ow rate of
5 l/min for the ¢rst 2 h and at 2 l/min for the following hours of
incubation. In previous experiments conducted under these conditions
[15], it was found that the pO2 measured in the media by an oxygen
electrode was 2 mm Hg after 2 h exposure to hypoxia and did not
£uctuate from this value throughout the remaining incubation period.
Within the hypoxia chamber, cells were maintained in a humidi¢ed
atmosphere at 37‡C.
2.3. Experimental protocol
The NO releasing agents, SNP and SNAP, were used in all experi-
ments. Cells were incubated for 6 h in complete medium (control),
medium supplemented with 0.5 mM SNP or 0.5 mM SNP plus 0.5
mM Hcy. In another set of experiments, cells were pre-treated with
0.5 mM Hcy for 18 h prior to exposure to SNP (0.5 mM) for 6 h. In
these experiments, SNP was added either to the original medium of
cells pre-treated with Hcy or the existing medium was replaced with
fresh medium containing SNP. Similar experiments were carried out
with SNAP. Cells were also treated with various concentrations of
Hcy for 6 or 18 h to exclude any potential e¡ect of this thiol com-
pound on HO-1 induction. For the experiments conducted under hy-
poxic conditions, cells were exposed to low oxygen tension (pO2W2
mm Hg) for 18 h with or without Hcy (0.5^1 mM). At the end of each
treatment, cells were collected and analysed for haem oxygenase ac-
tivity and HO-1 protein expression.
2.4. Assay for endothelial haem oxygenase activity
A haem oxygenase activity assay was performed as previously de-
scribed [12,15,18]. Brie£y, microsomes from harvested cells were
added to a reaction mixture containing NADPH, rat liver cytosol as
a source of biliverdin reductase and the substrate hemin. The reaction
was conducted at 37‡C in the dark for 1 h, terminated by the addition
of 1 ml of chloroform and the extracted bilirubin was calculated by
the di¡erence in absorbance between 464 and 530 nm (O= 40 mM31
cm31).
2.5. Western blot analysis for HO-1
Samples of endothelial cells treated for the haem oxygenase activity
assay were also analysed by Western immunoblot technique as pre-
viously described [12,15]. Brie£y, 30 Wg of protein from each sample
were separated by sodium dodecyl sulphate^polyacrylamide gel elec-
trophoresis, transferred overnight to nitrocellulose membranes and
the non-speci¢c binding of antibodies was blocked with 3% non-fat
dried milk in phosphate-bu¡ered saline (PBS). Membranes were then
probed with a polyclonal rabbit anti-HO-1 antibody (Stressgen, Vic-
toria, Canada) (1:1000 dilution in Tris-bu¡ered saline, pH 7.4) for 2 h
at room temperature. After three washes with PBS containing 0.05%
(v/v) Tween-20, blots were visualised using an ampli¢ed alkaline phos-
phatase kit from Sigma (Extra-3A) and the relative density of bands
analysed by an imaging densitometer (Model GS-700, Bio-Rad, Herts,
UK).
2.6. Statistical analysis
Di¡erences in data among the groups were analysed by using one-
way ANOVA combined with the Bonferroni test. Values were ex-
pressed as a mean þ S.E.M. and di¡erences between groups were con-
sidered to be signi¢cant at P6 0.05.
3. Results
3.1. E¡ect of Hcy on NO-mediated HO-1 induction in
endothelial cells
The e¡ect of SNP and Hcy on haem oxygenase activity and
HO-1 protein expression is shown in Fig. 1. Treatment of cells
with 0.5 mM SNP for 6 h resulted in a signi¢cant increase in
haem oxygenase activity from 171 þ 18 (control) to 1466 þ 165
pmol bilirubin/mg protein/h (Fig. 1A) con¢rming our previous
studies [12]. This e¡ect was attenuated by the presence of 0.5
mM Hcy (558 þ 47 pmol bilirubin/mg protein/h) (P6 0.05 ver-
sus control). Interestingly, pre-treatment of cells with Hcy for
18 h followed by addition of SNP to the original culture
medium also resulted in a signi¢cant decrease in haem oxy-
genase activity (P6 0.05). Addition of fresh medium contain-
ing SNP to cells pre-treated with Hcy still showed a reduced
activation of haem oxygenase; however, in this case the ac-
tivity was higher compared to cells treated with SNP added to
the original culture medium. Changes in haem oxygenase ac-
tivity were re£ected by changes in HO-1 levels as increased
HO-1 protein expression by SNP was signi¢cantly reduced by
the presence of Hcy in the culture media (Fig. 1B). Endothe-
lial cells exposed to SNAP for 6 h also resulted in augmented
haem oxygenase activity; however, this e¡ect was unaltered
by the presence of Hcy (Fig. 2). It is important to note that
treatment of cells with Hcy (0.5^1 mM) alone for 6 or 18 h
did not cause any change in haem oxygenase activity com-
pared to control (data not shown).
3.2. E¡ect of Hcy on hypoxia-mediated HO-1 induction in
endothelial cells
Exposure of endothelial cells to reduced oxygen tension
resulted in augmented HO-1 protein expression, which was
associated with a marked increase in haem oxygenase activity
(P6 0.01) (Fig. 3A,B). After 18 h hypoxia, haem oxygenase
activity increased from 171 þ 18 to 2917 þ 272 pmol bilirubin/
mg protein/h (P6 0.01). Interestingly, the presence of Hcy in
the culture media of cells exposed to hypoxia markedly re-
duced the increase in haem oxygenase activity in a concentra-
tion-dependent manner. Speci¢cally, as shown in Fig. 3A, 0.5
and 1 mM Hcy suppressed hypoxia-mediated haem oxygenase
activation by 79.7 and 93.7%, respectively (P6 0.01); this
Fig. 1. Modulatory e¡ect of Hcy on endothelial HO-1 induction
mediated by SNP. Endothelial haem oxygenase activity (A) and
HO-1 protein expression (B) were determined after 6 h incubation
(black bars) with 0.5 mM SNP, 0.5 mM Hcy or 0.5 mM SNP+0.5
mM Hcy. In additional experiments, cells were pre-treated for 18 h
with 0.5 mM Hcy followed by exposure to 0.5 mM SNP (grey
bars). In these experiments, SNP was added either to the original
medium of cells pre-treated with Hcy or the existing medium was
replaced with fresh medium (FM) containing SNP. *P6 0.05 versus
control (CON); 2P6 0.05 versus SNP; VP6 0.05 versus SNP+Hcy
(6 h).
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e¡ect was paralleled by a marked reduction in HO-1 protein
expression as revealed by Western blot analysis (Fig. 3B).
4. Discussion
Recent investigations from our group have demonstrated a
modulatory role of thiols and S-nitrosothiols in NO-mediated
induction of HO-1 in vascular endothelial cells [12,13,15,19].
Here, we extend our previous ¢ndings by showing that Hcy
interacts with NO to prevent the stimulation of endothelial
HO-1 expression and haem oxygenase activity by SNP, an
iron nitrosyl complex in which the NO is formally bound to
the metal centre as nitrosonium cation (NO). Hcy is known
to react with the NO group and stabilise it by formation of S-
nitrosohomocysteine [8,11] ; this is consistent with the notion
that NO can be transferred reversibly to cysteine residues
(trans-nitrosation) which are preferential targets of NO and
NO-related species [20]. Accordingly, compared to cells where
SNP and Hcy were added simultaneously to the starting me-
dium, cells pre-treated with Hcy for 18 h followed by addition
of fresh medium containing SNP still displayed a signi¢cant
elevation in haem oxygenase activity. These data suggest that
attenuation of HO-1 expression caused by Hcy is the conse-
quence of a direct interaction between the sulphur-containing
amino acid and the NO donor. Our data exclude the possi-
bility that oxidative stress mediated by hydrogen peroxide
originating from Hcy [1,7] is responsible for HO-1 induction
as haem oxygenase activity was unchanged after treatment of
cells with high levels of Hcy alone. We also found that acti-
vation of endothelial haem oxygenase by SNAP, a nitrosating
agent that release NO but to a certain extent also NO and
nitroxyl anion (NO3) [21,22], was not a¡ected by the presence
of Hcy in the starting medium. This could be related to the
di¡erent trans-nitrosation activities of SNP and SNAP to-
wards sulphydryl groups [22] and is in agreement with our
previous ¢ndings showing that much higher amounts of exog-
enous thiols are required to e¡ectively reduce SNAP-mediated
HO-1 induction in endothelial cells [12,23]. In view of the
multifactorial mechanism by which hyperhomocysteinemia
damages the endothelium leading to an impairment of vascu-
lar function, the data presented in this study highlight the
possibility that the decrease in antioxidant potential promoted
by Hcy in human endothelial cells could be related to its
negative e¡ect on the expression of important genes impli-
cated in cytoprotection [24].
As several cardiovascular-related diseases are characterised
by a reduction in oxygen availability, which renders the chal-
lenged tissue hypoxic, we designed experiments to examine the
possible modulatory e¡ect of Hcy on hypoxia-mediated HO-1
induction. Hypoxia is known to promote an increased gener-
ation of reactive oxygen species resulting in the induction of
distinctive genes whose expression is ¢nely regulated by redox
modi¢cation of transcription factors such as hypoxia induc-
ible factor-1 [25,26]. A previous report from our group dem-
onstrated that over-expression of HO-1 and the consequent
elevation in haem oxygenase activity of endothelial cells ex-
posed to hypoxia are associated with a transient formation of
endogenous S-nitrosothiols due to an early induction of the
iNOS gene [15]. We have also shown that iNOS inhibitors
signi¢cantly attenuate hypoxia-mediated HO-1 activation sug-
gesting that, in conditions of low oxygen tension, both oxida-
tive and nitrosative reactions actively contribute to the ob-
served stimulation of the HO-1 pathway [15]. In the present
study, we found that Hcy suppresses HO-1 protein expression
and prevents the increase in haem oxygenase activity caused
by hypoxia in a concentration-dependent manner. These data
suggest that high levels of Hcy may render the cardiovascular
system more vulnerable to oxidant-mediated injury since a
crucial role for the HO-1/bilirubin pathway in protection
against hypoxia-reoxygenation of cardiac tissue has been re-
cently demonstrated [27,28].
In conclusion, based on the data of the present study, we
propose that Hcy may contribute to vascular dysfunction by
preventing the inherent ability of endothelial cells to respond
Fig. 2. E¡ect of Hcy on SNAP-mediated haem oxygenase activation
in endothelial cells. Heme oxygenase activity was determined 6 h
after incubation of endothelial cells with 0.5 mM S-nitroso-N-acetyl-
penicillamine (SNAP) or 0.5 mM SNAP+0.5 mM Hcy. *P6 0.05
versus control.
Fig. 3. E¡ect of Hcy on hypoxia-mediated HO-1 induction in endo-
thelial cells. Heme oxygenase activity (A) and HO-1 protein expres-
sion (B) were determined 18 h after exposure of cells to hypoxic
conditions (pO2W2 mm Hg) in the presence or absence of Hcy
(0.5^1 mM). Control experiments are represented by cells incubated
under normoxic conditions for 18 h. *P6 0.01 versus control
(CON); 2P6 0.01 versus hypoxia (HYP).
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and adapt to stressful conditions. As the products of haem
degradation by augmented HO-1 act as important e¡ector
molecules in the restoration of vascular activities following
pathophysiological insults [14,27,29,30], chronic exposure to
hyperhomocysteinemia could signi¢cantly interfere with im-
portant transduction signals responsible for the activation of
HO-1 and other protective systems required to counteract the
diverse forms of stress [19]. In this context, the direct inter-
action of Hcy with NO groups in normal or hypoxic condi-
tions and the consequent impairment of NO’s biological ac-
tivity would exacerbate oxidative injury ultimately
contributing to endothelial cell dysfunction.
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